| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |